Mrinal(Laijawala)DutiaMD
Oncology • Sacramento, CAHematologic Oncology
Assistant Professor, Internal Medicine, UC, Davis School of Medicine
Dr. Dutia is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4501 X St
Ste 3016
Sacramento, CA 95817Phone+1 916-734-3771Fax+1 408-851-4319
Education & Training
University of California Davis HealthFellowship, Hematology and Medical Oncology, 2007 - 2010
Alameda Health System-Highland HospitalResidency, Internal Medicine, 2003 - 2007
Grant Medical CollegeClass of 2001
Certifications & Licensure
CA State Medical License 2005 - 2026
American Board of Internal Medicine Hematology- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012
Publications & Presentations
PubMed
- 60 citationsPhase I trial of arginine deprivation therapy with ADI-PEG 20 plus docetaxel in patients with advanced malignant solid tumorsBenjamin K. Tomlinson, Jim Thomson, John S. Bomalaski, Monica Diaz, Taiwo Akande
Clinical Cancer Research. 2015-06-01 - 64 citationsLenalidomide plus rituximab can produce durable clinical responses in patients with relapsed or refractory, indolent non-Hodgkin lymphoma.Joseph Tuscano, Mrinal Dutia, Karen Chee, Ann Brunson, Christine Reed-Pease
British Journal of Haematology. 2014-05-01 - 11 citationsPhase I study of the combination of temsirolimus and pazopanib in advanced solid tumorsThomas J. Semrad, Courtney Eddings, Mrinal Dutia, Scott D Christensen, Primo N. Lara
Anti-Cancer Drugs. 2013-07-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
